Spots Global Cancer Trial Database for prednisolone
Every month we try and update this database with for prednisolone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma | NCT04780464 | Advanced Soft-t... | Doxorubicin Doxorubicin Cyclophosphamid... Prednisolone Prednisone | 65 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission. | NCT05990985 | Diffuse Large B... | Mitoxantrone hy... RiTUXimab Injec... Cyclophosphamid Vincristine Prednisolone | 18 Years - | The First Hospital of Jilin University | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | NCT00275106 | Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisolone thioguanine vincristine sul... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Immune Suppression Of Infants Treated With Steroids | NCT00433940 | Hemangioma | Prednisolone | - 6 Months | Medical College of Wisconsin | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy | NCT01485861 | Prostate Cancer | Abiraterone Apitolisib Ipatasertib Placebo Prednisone Prednisolone | 18 Years - | Genentech, Inc. | |
| Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | NCT00379574 | Lymphoma, Large... Lymphoma, B-Cel... | Bortezomib Cyclophosphamid... Doxorubicin Vincristine Prednisolone Lenograstim | 15 Years - 70 Years | Asan Medical Center | |
| Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia | NCT00550992 | Leukemia | anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ... | - 1 Year | Dutch Childhood Oncology Group | |
| A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia | NCT05761171 | Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Mixed... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Mixe... | Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cytarabine Echocardiograph... Fludarabine Pho... Hydrocortisone ... Lumbar Puncture Methotrexate Multigated Acqu... Prednisolone Prednisone Revumenib Vincristine Sul... | 1 Month - 6 Years | Children's Oncology Group | |
| A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | NCT01834209 | Prostate Neopla... | Abiraterone ace... Prednisone or p... | 18 Years - | Janssen Research & Development, LLC | |
| Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) | NCT03834519 | Prostatic Neopl... | Pembrolizumab Olaparib Abiraterone ace... Prednisone Enzalutamide Prednisolone | 18 Years - | Merck Sharp & Dohme LLC | |
| Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer | NCT02074137 | Prostate Cancer... | CABAZITAXEL XRP... Prednisone Prednisolone | 18 Years - | Sanofi | |
| Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | NCT02894645 | Acute Lymphobla... | Prednisolone Dexamethasone L-Asparaginase Vincristine Methotrexate Daunorubicin Doxorubicin Cyclophosphamid... Cytarabine 6-Mercaptopurin... Thioguanine Fludarabine Imatinib | 1 Year - 17 Years | National University Hospital, Singapore | |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers | NCT00822809 | Cancer Neoplasms Carcinoma Malignant Ascit... | Catumaxomab Prednisolone | 18 Years - | Neovii Biotech | |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | NCT00002532 | Leukemia | filgrastim asparaginase cytarabine daunorubicin hy... dexamethasone etoposide idarubicin ifosfamide leucovorin calc... methotrexate prednisolone vindesine | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | NCT01908972 | Hemangioma | Prednisolone Propranolol | - 9 Months | Seoul National University Hospital | |
| A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma | NCT01992653 | Lymphoma, Non H... | Cyclophosphamid... Doxorubicin Obinutuzumab Polatuzumab Ved... Prednisolone Prednisone Rituximab | 18 Years - | Genentech, Inc. | |
| TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | NCT00002757 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul... | - 20 Years | Children's Oncology Group | |
| Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) | NCT00130195 | Acute Lymphobla... | imatinib cyclophosphamid... daunorubicin vincristine prednisolone methotrexate cytarabine dexamethasone | 15 Years - 64 Years | Japan Adult Leukemia Study Group | |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) | NCT03792256 | Leukemia, Lymph... Lymphoblastic L... T-cell Lymphoma T-cell Leukemia Recurrent Disea... Acute Leukemia | Palbociclib Cytarabine Methotrexate Hydrocortisone Doxorubicin Prednisolone Vincristine Pegaspargase Hydrocortisone Prednisone | 12 Months - 31 Years | Children's Oncology Group | |
| Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | NCT00687648 | Breast Cancer | anastrozole cyclophosphamid... exemestane letrozole methotrexate prednisolone | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) | NCT05406401 | Lymphoma, Large... | Zilovertamab Ve... Cyclophosphamid... Doxorubicin Rituximab Rituximab Biosi... Prednisone Prednisolone | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma | NCT01884428 | Hodgkin's Lymph... | panobinostat Ifosfamide Gemcitabine Vinorelbine Prednisolone | 18 Years - 65 Years | Istituto Clinico Humanitas | |
| Immune Suppression Of Infants Treated With Steroids | NCT00433940 | Hemangioma | Prednisolone | - 6 Months | Medical College of Wisconsin | |
| Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00003815 | Lymphoma | bleomycin sulfa... carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide melphalan prednisolone vincristine sul... autologous bone... radiation thera... | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia | NCT00526409 | Acute Lymphobla... | Prednisolone Daunorubicin Vincristine L-Asparaginase Cyclophosphamid... Methotrexate Cytosine Arabin... | - 16 Years | PETHEMA Foundation | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | NCT04736108 | Prostate Cancer | Abiraterone ace... Prednisolone Goserelin | 18 Years - | West China Hospital | |
| Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | NCT00002531 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone teniposide thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... radiation thera... | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) | NCT05406401 | Lymphoma, Large... | Zilovertamab Ve... Cyclophosphamid... Doxorubicin Rituximab Rituximab Biosi... Prednisone Prednisolone | 18 Years - | Merck Sharp & Dohme LLC | |
| Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | NCT03206671 | Mature B-cell N... | Rituximab windo... Additional dose... Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin hyd... Vindesine Sulfa... Etoposide Ifosfamide Methotrexate Prednisolone Vincristine | - 18 Years | University Hospital Muenster | |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer | NCT02441894 | Prostate Cancer | CABAZITAXEL XRP... PEG-G-CSF Prednisolone Dexchlorphenira... Ranitidine Metoclopramide,... Dexamethasone | 20 Years - | Sanofi | |
| Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | NCT00687648 | Breast Cancer | anastrozole cyclophosphamid... exemestane letrozole methotrexate prednisolone | 18 Years - | National Cancer Institute (NCI) | |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | NCT00967226 | Hemangioma of I... | propranolol Prednisolone | 2 Weeks - 6 Months | Children's National Research Institute | |
| A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | NCT06320067 | Prostate Cancer... | Stereotactic Ab... 177Lu-PSMA-617 Niraparib and A... Abiraterone Ace... Apalutamide Androgen Depriv... Androgen Recept... Local Radiother... Prednisolone Docetaxel | 18 Years - | University College, London | |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer | NCT02441894 | Prostate Cancer | CABAZITAXEL XRP... PEG-G-CSF Prednisolone Dexchlorphenira... Ranitidine Metoclopramide,... Dexamethasone | 20 Years - | Sanofi | |
| Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | NCT00131053 | Lymphoblastic L... | Methotrexate Prednisolone Dexamethasone Vincristine Pirarubicin Cyclophosphamid... L-asparaginase Cytarabine Hydrocortisone Mercaptopurine | 15 Years - 24 Years | Japan Adult Leukemia Study Group | |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | NCT03914625 | B Acute Lymphob... B Lymphoblastic... Down Syndrome | Asparaginase Er... Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Mercaptopurine ... Methotrexate Pegaspargase Prednisolone Prednisone Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul... | 365 Days - 31 Years | National Cancer Institute (NCI) | |
| A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy | NCT02405858 | Metastatic Cast... | Abiraterone Ace... Prednisolone | 20 Years - | Janssen Pharmaceutical K.K. | |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | NCT00967226 | Hemangioma of I... | propranolol Prednisolone | 2 Weeks - 6 Months | Children's National Research Institute | |
| A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat | NCT05320380 | Recurrent Acute... Recurrent B Acu... Recurrent Mixed... Recurrent T Acu... Refractory Acut... Refractory B Ac... Refractory Mixe... Refractory T Ac... | Anti-CD123 ADC ... Bone Marrow Asp... Cytarabine Fludarabine Pho... Hydrocortisone ... Liposome-encaps... Methotrexate Prednisolone | 12 Months - 22 Years | Children's Oncology Group | |
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | NCT05675410 | Lugano Classifi... | Biospecimen Col... Bleomycin Sulfa... Brentuximab Ved... Computed Tomogr... Cyclophosphamid... Dacarbazine Doxorubicin Hyd... Etoposide Etoposide Phosp... Fludeoxyglucose... Involved-site R... Magnetic Resona... Nivolumab Positron Emissi... Prednisolone Prednisone Procarbazine Hy... Questionnaire A... Vinblastine Sul... Vincristine Sul... | 5 Years - 60 Years | National Cancer Institute (NCI) | |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL | NCT01897571 | B-cell Lymphoma... Advanced Solid ... Diffuse Large B... Follicular Lymp... Transformed Fol... Primary Mediast... | Tazemetostat Prednisolone Tazemetostat | 16 Years - | Ipsen | |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
| A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) | NCT06124157 | B Acute Lymphob... | Biospecimen Col... Blinatumomab Bone Marrow Bio... Calaspargase Pe... Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Doxorubicin Echocardiograph... Leucovorin Mercaptopurine Methotrexate Multigated Acqu... Pegaspargase Prednisolone Prednisone Radiation Thera... Thioguanine Vincristine | 366 Days - 46 Years | National Cancer Institute (NCI) | |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer | NCT04071262 | Advanced Cancer | Abemaciclib Abiraterone Ace... Prednisolone | 20 Years - | Eli Lilly and Company | |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement | NCT02828358 | Acute Leukemia ... B Acute Lymphob... Mixed Phenotype... | Azacitidine Cyclophosphamid... Cytarabine Daunorubicin Daunorubicin Hy... Dexamethasone Hydrocortisone ... Laboratory Biom... Leucovorin Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Pharmacological... Prednisolone Thioguanine Vincristine Vincristine Sul... | - 364 Days | National Cancer Institute (NCI) | |
| PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | NCT00291005 | Prostatic Neopl... | ARD6562, Doceta... | 20 Years - 74 Years | Sanofi | |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer | NCT04071262 | Advanced Cancer | Abemaciclib Abiraterone Ace... Prednisolone | 20 Years - | Eli Lilly and Company | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | NCT00474383 | Prostate Neopla... | Abiraterone ace... Glucocorticoid | 18 Years - | Cougar Biotechnology, Inc. | |
| Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | NCT00002576 | Lymphoma | cyclophosphamid... doxorubicin hyd... mitoxantrone hy... prednisolone vincristine sul... | 65 Years - | National Cancer Institute (NCI) | |
| Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma | NCT01088750 | Lymphoma | cyclophosphamid... prednisolone vinblastine sul... watchful waitin... therapeutic con... | - 17 Years | Martin-Luther-Universität Halle-Wittenberg | |
| Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | NCT02229136 | Stomatitis Oral Mucositis Neoplasm of the... Malignant Tumor... | Miracle Mouthwa... Prednisolone | 18 Years - | US Oncology Research | |
| A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | NCT06320067 | Prostate Cancer... | Stereotactic Ab... 177Lu-PSMA-617 Niraparib and A... Abiraterone Ace... Apalutamide Androgen Depriv... Androgen Recept... Local Radiother... Prednisolone Docetaxel | 18 Years - | University College, London | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | NCT03914625 | B Acute Lymphob... B Lymphoblastic... Down Syndrome | Asparaginase Er... Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Mercaptopurine ... Methotrexate Pegaspargase Prednisolone Prednisone Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul... | 365 Days - 31 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | NCT00312520 | Hemangiomas | prednisolone methylprednisol... | 1 Month - 4 Months | The Hospital for Sick Children | |
| Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma | NCT01884428 | Hodgkin's Lymph... | panobinostat Ifosfamide Gemcitabine Vinorelbine Prednisolone | 18 Years - 65 Years | Istituto Clinico Humanitas | |
| Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | NCT02121639 | Prostate Cancer | Placebo AZD5363 | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | NCT00002700 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera... | 15 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | NCT02121639 | Prostate Cancer | Placebo AZD5363 | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | NCT01324583 | Prostate Cancer | Cabazitaxel (XR... prednisolone | 20 Years - 73 Years | Sanofi | |
| The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | NCT01908972 | Hemangioma | Prednisolone Propranolol | - 9 Months | Seoul National University Hospital | |
| Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001) | NCT01370694 | Follicular Lymp... | MK-8808 cyclophosphamid... vincristine prednisolone | 18 Years - | Merck Sharp & Dohme LLC | |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel | NCT01795703 | Prostate Cancer | Abiraterone Prednisolone | 20 Years - | Janssen Research & Development, LLC | |
| Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | NCT00268476 | Prostate Cancer | Celecoxib Docetaxel Prednisolone ADT Zoledronic Acid Abiraterone Radiotherapy to... Enzalutamide Metformin Transdermal Oes... | - 120 Years | Medical Research Council | |
| PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | NCT00291005 | Prostatic Neopl... | ARD6562, Doceta... | 20 Years - 74 Years | Sanofi | |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL | NCT01897571 | B-cell Lymphoma... Advanced Solid ... Diffuse Large B... Follicular Lymp... Transformed Fol... Primary Mediast... | Tazemetostat Prednisolone Tazemetostat | 16 Years - | Ipsen | |
| Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01005758 | Leukemia | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | NCT02229136 | Stomatitis Oral Mucositis Neoplasm of the... Malignant Tumor... | Miracle Mouthwa... Prednisolone | 18 Years - | US Oncology Research | |
| Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOS | NCT02344888 | Infertility Polycystic Ovar... | Clomiphene citr... Clomiphene citr... | 20 Years - 35 Years | Mansoura University | |
| A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone | NCT02288247 | Metastatic Cast... | Enzalutamide Docetaxel Prednisolone Placebo | 18 Years - | Astellas Pharma Inc | |
| Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma | NCT00637832 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisolone vincristine sul... yttrium Y 90 ib... | 18 Years - 120 Years | University of Southampton | |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel | NCT01795703 | Prostate Cancer | Abiraterone Prednisolone | 20 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
